Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats

Asian Journal of Andrology

Volumn 14, Issue 2, 2012, Pages 320-324

  Lee, Mee Young ^a   Shin, In Sik ^a   Seo, Chang Seob ^a   Lee, Nam Hun ^a   Ha, Hye Kyung ^a   Son, Jong Keun ^b   Shin, Hyeun Kyoo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

benign prostatic hyperplasia; dihydrotestosterone; Melandrium firmum (S. et Z.)ROHRB; prostate; testosterone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROSTANOLONE; ASPARTATE AMINOTRANSFERASE; HERBACEOUS AGENT; MELANDRIUM FIRMUM METHANOLIC EXTRACT; METHANOL; PENTOBARBITAL; PLANT EXTRACT; TESTOSTERONE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MALE; MEDICINAL PLANT; MELANDRIUM FIRMUM; NONHUMAN; PROSTATE; PROSTATE HYPERTROPHY; RAT; SCROTUM; SOLVENT EXTRACTION; TESTOSTERONE BLOOD LEVEL; TISSUE LEVEL;

ADMINISTRATION, ORAL; ANIMALS; CARYOPHYLLACEAE; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; MALE; METHANOL; ORCHIECTOMY; ORGAN SIZE; PLANT EXTRACTS; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; TESTOSTERONE;

EID: 84863296336     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.166     Document Type: Article

References (36)

1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 1256-61. (Pubitemid 40380548)
2. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety Study Group. N Engl J Med 1998; 338: 557-63. (Pubitemid 28114643)
3. Foley CL, Kirby RS. 5 alpha-reductase inhibitors: What's new? Curr Opin Urol 2003; 13: 31-7. (Pubitemid 36106327)
4. Vaughan D, Imperato-McGinley J, McConnell J, Matsumoto AM, BrackenBet al. Longterm (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology 2002; 60: 1040-4. (Pubitemid 35447563)
5. Uygur MC, Gur E, Arik AI, Altug U, Erol D. Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study. Andrologia 1998; 30: 5-10. (Pubitemid 28175462)
6. Chang IS, Han YB, Woo WS, Kang SS, Lotter H et al. 1989. Sapogenins from Melandrium firmum. Planta Med 1989; 55: 544-7. (Pubitemid 20059697)
7. Woo EH, Woo WS, Chmurny GN, Hilton BD. Melandrioside a saponin from Melandrium firmum. J Nat Prod 1992; 55: 786-94.
8. Zhen MS, Hwang NK, Kim DH, Moon TC, Song JK et al. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. Arch Pharm Res 2008; 31: 318-22.
9. Perry LM. Medicinal Plants of East and Southeast Asia, Attributed Properties and Uses. Cambridge, CA/London: MIT Press; 1980. p74.
10. Sharaf M, el-Ansari MA, Matlin SA, Saleh NA. Four flavonoid glycosides from Peganum harmala. Phytochemistry 1997; 44: 533-6. (Pubitemid 27100319)
11. Naslund MJ, Coffey DS. The differential effects of neonatal androgens, estrogen and progesterone on adult rat prostate growth. J Urol 1986; 136: 1136-40. (Pubitemid 17175013)
12. Guo QL, Ding GL, Wu ZQ. Effect of baicalein on experimental prostatic hyperplasia in rats and mice. Biol Pharm Bull 2004; 27: 333-7.
13. di Salle E, Giudici D, Biagini L, Cominato C, Briatico G et al. Effects of 5 alphareductase inhibitors on intraprostatic androgens in the rat. J Steroid Biochem Mol Biol 1995; 53: 381-5.
14. Huynh H. Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins. Int J Oncol 2002; 20: 1297-303.
15. Arruzazabala ML, Mas R, Molina V, Noa M, Carbajal D et al. Effect of D-004, a lipid extract from the cubal royal palm fruit, on atypical prostate hyperplasia induced by phynylephrine. Drug R D 2006; 7: 233-41. (Pubitemid 43927203)
16. Veeresh Babu, SV, Veeresh B, Patill AA, Warke YB. Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. Eur J Pharmacol 2010; 625: 262-5.
17. Furuya S, Kumamoto Y, Yokoyama E, Tsukamoto T, Izumi T et al. Alphaadrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 1982; 128: 836-9. (Pubitemid 13236377)
18. Griffiths K, Denis LJ. Exploitable mechanisms for the blockade of androgenic action. Prostate Suppl 2000; 10: 43-51.
19. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S et al. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride. Endocrinology 1995; 136: 741-8.
20. Lobaccaro JM, Boudon C, Lechevallier E, Mottet N, Rebillard X et al. Effect of finasteride (Proscar) on the proliferation of cultured epithelial and stromal cells from normal and hyperplastic human prostates. Cell Mol Biol 1996; 42: 511-8.
21. Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate. Prostate 1996; 29: 1-14. (Pubitemid 26250364)
22. Huynh H. Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins. Int J Oncol 2002; 20: 1297-303.
23. Aryal M, Pandeya A, Gautam N, Baral N, Lamsal M et al. Oxidative stress in benign prostatic hyperplasia. Nepal Med Coll J 2007; 9: 222-4.
24. Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 2006; 39: 176-9. (Pubitemid 43255508)
25. Mchedlidze MG, Shioshvili TI. Influence of antioxidants on the development of benign prostatic hyperplasia. Georgian Med News 2006; 140: 23-7.
26. Siddiqui IA, Raisuddin S, Shukla Y. Protective effects of black tea extract on testosterone induced oxidative damage in prostate. Cancer Lett 2005; 227: 125-32. (Pubitemid 41169925)
27. Prasad S, Kalra N, Singh M, Shukla Y. Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss. Asian J Androl 2008; 10: 313-8. (Pubitemid 351337996)
28. Lopez E, Molina V, Illnait J, Oyarzabal A, Fernandez LC et al. Antioxidant effects of D- 004, a lipid extract from the Roystonea regia fruit, on the plasma of healthy men. Asian J Androl 2009; 11: 385-92.
29. Hevesi BT, Houghton PJ, Habtemariam S, Kery A. Antioxidant and anti-inflammatory effect of Epilobium parviflorum Schreb. Phytother Res 2009; 23: 719-24.
30. Belostottskaia LI, Nikitchenko IuB, Gomon N, Chaika LA, Bordar VV et al. Effect of biologically active substances of animal and plant origin on prooxidant-antioxidant balance in rats with experimental prostatic hyperplasia. Eksp Klin Farmakol 2006; 4: 66-8. (Pubitemid 44449021)
31. Ying XX, Li HB, Chu ZY, Zhai YJ, Leng AJ et al. HPLC determination of malondialdehyde in ECV304 cell culture medium for measuring the antioxidant effect of vitexin-40-O-glucoside. Arch Pharm Res 2008; 31: 878-85.
32. Li HB, Ying XX, Lu J. The mechanism of vitexin-40-O-glucoside protecting ECV-304 cells against tertbutyl hydroperoxide induced injury. Nat Prod Res 2010; 24: 1695-703.
33. Zheng MS, Hwang NK, Kim DH, Moon TC, Son JK et al. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. Arch Pharm Res 2008; 31: 318-22.
34. Woo EH, Woo WS. Melandrioside A, a saponin from Melandrium firmum. J Nat Prod 1992; 55: 786-94.
35. Besson E, Besset A, Bouillant ML, Chopin J, Brederode J et al. Genetically controlled 20-O-glycosylation of isovitexin in the petals of Melandrium album. Phytochemistry 1979; 18: 657-8.
36. Darmograi VN. Flavonoids from certain species of the genus Melandrium. Khimiya Prirodnykh Soedinenii 1977; 1: 115-6.